© 2021 MJH Life Sciences and Consultant Live. All rights reserved.
June 03, 2020
The most recent protests to police brutality, and the ensuing violence across cities and towns, sparked response from most national medical institutions—who for decades have sought to address disparities in care.
March 28, 2020
The Abbott-developed test platform is already used as a molecular point-of-care device for influenza A and B, Strep A, and respiratory syncytial virus.
February 20, 2020
Younger patients display increased susceptibility to H1N1 relative to H3N2, according to study findings.
February 19, 2020
The Prometra II offers a pressure-driven, valve-gated delivery mechanism that allows for novel programming modes of intermittent flow followed by periods of no flow—a feature unique to this device.